Germline BRCA1 and BRCA2 deleterious mutations and variants of unknown clinical significance associated with breast/ovarian cancer

Dr Anuj ParkashWritten by | 18/12/2018| PATHOLOGY, Undergraduate Learning

Email this to someoneShare on FacebookTweet about this on TwitterPrint this pageShare on LinkedInShare on Google+
Loader Loading...
EAD Logo Taking too long?

Reload Reload document
| Open Open in new tab
Email this to someoneShare on FacebookTweet about this on TwitterPrint this pageShare on LinkedInShare on Google+

Last modified: 18/12/2018

Previous Story
Immunohistochemistry : An essential tool for complete Anatomical Pathology Portfolio in cancer management
Next Story
BRCA1 and BRCA2 Mutations in Ovarian Cancer

Leave a Reply

Your email address will not be published. Required fields are marked *